1 citations
,
March 2023 in “Phytochemistry Reviews” This review discusses the potential of CBD for treating skin disorders, the challenges of its topical administration, and current strategies to improve its application, but reports no new clinical findings.
1 citations
,
January 2022 in “BioMed Research International” This study reported that solid lipid nanoparticles of finasteride decorated with chitosan enhanced drug retention in skin layers, suggesting potential application in treating androgenic alopecia and benign prostate hyperplasia with fewer side effects.
1 citations
,
December 2013 in “The journal of investigative dermatology. Symposium proceedings/The Journal of investigative dermatology symposium proceedings” This review discusses the National Alopecia Areata Foundation's efforts to evaluate and advance alopecia areata research, focusing on immunology and drug development, and reports no new clinical results.
September 2026 in “Journal of Cosmetic Dermatology” This scoping review reports that preclinical studies suggest omega fatty acids may promote hair follicle growth, but clinical evidence is mixed, with no support for their standalone use in treating alopecia.
June 2026 in “Journal of Cosmetic Dermatology” In this study, digital treatment for androgenetic alopecia over six months led to significant improvements in quality of life among Brazilian men, particularly for those with consistent program adherence, although the absence of an in-person comparator limits causal conclusions.
This study highlights the increasing association between popular diets, unregulated supplements, and various skin disorders, emphasizing the need for clinicians to thoroughly assess dietary histories to manage nutrition-related skin issues effectively.
May 2024 in “International Journal of Nanomedicine” This review examined the diverse therapeutic potentials of cannabinoids, highlighting their applications in pain, neurological, and cancer treatments, and emphasized the benefits of biodegradable polymers in improving drug delivery; however, further clinical trials are needed to fully explore these potentials.
In this study, researchers found that biotin levels increase with age but not gender, and there is a notable negative relationship between biotin levels and triglyceride levels, suggesting biotin should be checked in patients with high triglyceride levels.
March 2023 in “Journal of Personalized Medicine” During LIFEHOUSE, researchers documented distinct patterns of physical exam findings and biomarker abnormalities in 369 adult employees, which may aid clinicians in recognizing wellness challenges and preventing chronic diseases associated with aging.
June 2026 in “International Journal of Molecular Sciences” This review synthesizes current evidence on the Warburg effect in anaplastic thyroid carcinoma and discusses potential therapeutic targets, but reports no new clinical results.
June 2026 in “Dove Medical Press (Taylor and Francis Group)” This paper reviews existing and emerging therapies for alopecia areata, describing the impact of targeted treatments in this field, and introduces a global network of disease registers to study the long-term safety and effectiveness of these new options.
This source reports that telogenic hair loss, while not leading to complete baldness, significantly impacts patients' quality of life due to its effects on their psychoemotional state; no standardized treatment currently exists, so therapy focuses on addressing trigger factors and psychological well-being.
January 2026 in “Pharmaceutical Medicine” January 2026 in “Neurochemistry International” This study reports that in human glioblastoma and neuroblastoma cell lines, 24-hydroxycholesterol significantly suppressed the conversion of testosterone to growth-inducing androgens via the 5α-reductase pathway, revealing a new connection between cholesterol homeostasis and androgen metabolism.
December 2025 in “PLOS Global Public Health” This study assessed women in Bangladesh and found that those with PCOS had markedly higher rates of depression, anxiety, stress, and insomnia compared to those without the condition, with rural women showing higher anxiety and insomnia.
December 2025 in “Processes” This study found that minoxidil had the highest solubility in shea butter, stearic acid, and rosemary oil, suggesting these natural oils may improve drug loading and encapsulation efficiency in lipid nanocarrier formulations for potential hair growth applications.
November 2025 in “British Journal of Dermatology” This guideline by the British Association of Dermatologists reviews managing alopecia areata and provides 56 recommendations but reports no new clinical results.
This article discusses the lack of effective drugs for treating graying hair and explores current therapies for age-related hair changes, emphasizing the importance of addressing general health issues and nutrient supplementation for hair health.
January 2025 in “Pharmaceuticals” This review discusses the role of nanocarrier systems, such as nanoemulsions and liposomes, in delivering antioxidants into the skin to counteract oxidative stress, highlighting recent advancements in topical antioxidant therapy through nanotechnology.
June 2024 in “Pharmacon Jurnal Farmasi Indonesia” In this study, researchers evaluated different formulations of a nanoemulsion combining candlenut oil and virgin coconut oil on male rats and found that a 1:3 ratio yielded significant hair growth results, with an average hair length of 17.14 mm and a weight of 699.37 mg.
April 2024 in “AAPS PharmSciTech” New microneedle method improves hair regrowth treatment delivery.
January 2024 in “Medicina” This study assessed outcomes and complications of upper-face feminization surgery among 20 transgender patients, highlighting that insufficient browbone reduction was a common issue in prior surgeries, and emphasizing meticulous planning to prevent revisions and dissatisfaction.
June 2023 in “JAAD Case Reports” This article reviews the epidemiology of desmoplastic melanoma and reports no new clinical findings, emphasizing higher risks in chronically sun-exposed older males.
May 2023 in “Journal of Pharmaceutical Innovation”
May 2023 in “Journal of Clinical Medicine” This review article reports recent advancements in understanding, diagnosing, and treating various hair loss conditions, like androgenetic alopecia and alopecia areata, including their genetic factors and new therapeutic options, while also examining the impact of COVID-19 on hair loss.
May 2022 in “Liver transplantation” This source does not report original research findings but reviews the mechanisms and challenges of immune response and immunosuppressive management in liver transplantation.
September 2021 in “Assay and drug development technologies” This review covers drug repurposing patent applications from April to June 2021, detailing potential new therapeutic uses for existing medications, but reports no new clinical results; the authors highlight novel treatment possibilities and suggest further research.
January 2019 in “Springer eBooks” Combination therapies might work better for some vitiligo patients, but results vary.
February 2009 in “Journal of the American Academy of Dermatology” November 2008 in “Journal of the American Academy of Dermatology”